Recent SPRO News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 09:01:05 PM
- Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business Update • GlobeNewswire Inc. • 10/29/2024 08:05:00 PM
- Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024 • GlobeNewswire Inc. • 10/16/2024 08:05:00 PM
- Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy • GlobeNewswire Inc. • 10/02/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 10:56:05 AM
- Spero Therapeutics to Present at Upcoming September Investor Conferences • GlobeNewswire Inc. • 09/04/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2024 10:43:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2024 10:42:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2024 10:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 11:56:12 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/05/2024 08:25:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/05/2024 08:18:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:13:08 PM
- Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update • GlobeNewswire Inc. • 08/05/2024 08:01:00 PM
- Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024 • GlobeNewswire Inc. • 07/29/2024 08:05:16 PM
- Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/03/2024 05:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:15:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:25:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:02:29 PM
- U.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices Drop • IH Market News • 05/15/2024 11:50:05 AM
- Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024 • GlobeNewswire Inc. • 03/06/2024 01:05:00 PM
- Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections • GlobeNewswire Inc. • 02/28/2024 01:05:00 PM
- Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference • GlobeNewswire Inc. • 02/26/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:05:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 01:53:34 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM